
The project’s findings provide new insights into how the skin prevents substances from entering the body and may contribute to the development of more effective drugs applied directly to the skin.
Members of the Skin Barrier Research Group participated in Skin Forum 2026, held in Malmö, Sweden, on 23–24 June 2026.
On June 2 and 3, 2026, the FA&CE 2026 conference was held at the Faculty of Pharmacy of Charles University in Hradec Králové in cooperation with the Jagiellonian University in Krakow.
At the 39th Annual ACS National Medicinal Chemistry Symposium, held from May 31 to June 3, 2026, in Atlanta, USA, the Faculty of Pharmacy in Hradec Králové was represented by Mgr. Eliška Cejnarová.
Modern drugs that target the EGFR protein have revolutionized the treatment of non-small cell lung cancer. However, their long-term effectiveness is often limited by the development of drug resistance.